文献速递神经儿科影像MR

儿童低级别胶质瘤多模态数据的不确定性风险分层

Uncertainty-Aware Risk Stratification in Pediatric Low-Grade Glioma Using Multimodal Data.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-07-29

该研究利用儿童脑肿瘤网络数据,开发了整合T2加权MRI深度学习特征、分子亚型与临床信息的不确定性多模态生存模型。深度学习影像模型在发现与重复队列的C指数分别为0.73和0.70,加入分子亚型后可改善重复队列风险分层。多模态融合后预测不确定性明显下降。

要点

  • T2加权MRI深度学习特征可与多参数影像组学效果相当,阅片时可重点关注肿瘤分割相关区域。
  • 分子亚型加入临床-影像模型后主要改善重复队列预后分层,建议结合分子信息评估。
  • 多模态融合降低个体预测不确定性,有利于报告中对预后判断的可靠性说明。

核心结论

  • 在儿童低级别胶质瘤中,将分子亚型整合到临床-影像生存框架可改善风险分层。
  • 从T2加权MRI提取的深度学习特征无需复杂肿瘤分割即可达到与多参数影像组学相当的性能。
  • 不确定性感知的多模态生存模型可作为更精简、更透明的儿童低级别胶质瘤风险分层方法。

研究设计与样本

  • 研究类型为基于公开数据库的回顾性预后模型开发与验证研究。
  • 数据来自儿童脑肿瘤网络,影像队列360例,分子亚型队列493例,所有患者均有临床数据。
  • 使用预训练深度学习模型在752例儿童脑肿瘤队列上微调肿瘤分割,再用于T2加权MRI影像特征提取。
  • 临床-影像生存模型(DL-M1)与临床-分子生存模型在发现队列训练验证,并在独立重复队列评估。
  • 在同时具备影像与分子数据的294例患者中通过晚期融合建立多模态模型DL-M2,并用Bootstrap重采样量化个体预测不确定性。

关键影像表现/征象

  • 从T2加权MRI中提取的深度学习影像特征用于风险分层,原文未描述具体的信号或形态学影像征象。
  • 多模态模型将18例患者重新分层,且结果与已知的BRAF相关预后生物学特征一致。

诊断标准与关键数值

  • 临床-影像模型在发现队列Harrell C指数为0.73(95%CI:0.68-0.78),重复队列为0.70。
  • 临床-影像模型与多参数影像组学管线性能相当,差异无统计学意义(p>0.05)。
  • 加入分子亚型后重复队列C指数由0.63提高至0.68(p=0.016),发现队列由0.78提高至0.79(p=0.26)。
  • 不确定性分析显示晚期融合后Bootstrap置信区间宽度中位数在发现队列由2.37降至0.57,降低75.8%。
  • 重复队列置信区间宽度中位数由2.32降至0.60,相对降低75.2%。

临床应用与阅片要点

  • 对于仅行T2加权MRI的儿童低级别胶质瘤患者,可考虑采用深度学习影像特征辅助风险分层。
  • 报告中提示预后时应结合分子亚型信息,尤其在独立外部人群中分子信息可带来额外分层价值。
  • 使用多模态模型并关注预测不确定性,有助于避免对单一模型风险估计的过度解读。

局限性

  • T2加权MRI深度学习特征的具体定义与影像判读可重复性需在临床环境中进一步验证。
  • 原文未提供前瞻性验证结果,因此其临床应用稳定性尚待确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Risk stratification in pediatric low-grade glioma (pLGG) remains challenging due to biological and clinical heterogeneity. We developed an uncertainty-aware multimodal survival framework that integrates deep learning features from T2-weighted MRI, molecular subtype, and clinical information.

MATERIALS AND METHODS: Data from the Children's Brain Tumor Network included 360 subjects with imaging data and 493 with molecular subtype information derived from tumor tissue genomic profiling; clinical data were available for all patients. A pretrained deep learning model was fine-tuned for tumor segmentation using a pediatric brain tumor cohort (n=752) and subsequently used to extract imaging features from T2-weighted MRI. A regularized survival model integrating imaging and clinical features (clinico-ResNet; DL-M1) and a separate clinical-molecular survival model were trained and validated on discovery cohorts and evaluated on independent replication cohorts. A multimodal model (DL-M2), combining risk scores from the clinico-ResNet and clinical-molecular models through late fusion, was developed in the subsect of patients with both imaging and molecular data (n=294). Bootstrap resampling was used to quantify per-patient prediction uncertainty.

RESULTS: DL-M1 achieved Harrell's C-indices of 0.73 (95% CI: 0.68-0.78) and 0.70 in the discovery and replication cohorts, respectively, with performance statistically comparable to a multiparametric radiomic pipeline (p>0.05). Adding molecular subtype information improved performance in the replication cohort (C-index: 0.68 vs 0.63, p=0.016) but not in the discovery cohort (0.79 vs 0.78, p=0.26). The multimodal model reclassified 18 patients in a manner consistent with established BRAF-associated prognostic biology. Uncertainty analysis showed a marked reduction in bootstrap confidence interval widths following late fusion with the molecular model, decreasing from a median of 2.37 to 0.57 in the discovery cohort and from 2.32 to 0.60 in the replication cohort, corresponding to relative reductions of 75.8% and 75.2%, respectively.

CONCLUSIONS: Integrating molecular subtype into a clinical-imaging survival framework improved risk stratification in pLGG. Deep learning features extracted from T2-weighted MRI achieved performance comparable to a multiparametric radiomics pipeline without complex tumor segmentation. These findings support uncertainty-aware multimodal survival modeling as a streamlined and more transparent approach for pLGG risk stratification.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Batal, Vunnava, Kraya, et al. Uncertainty-Aware Risk Stratification in Pediatric Low-Grade Glioma Using Multimodal Data. AJNR Am J Neuroradiol. 2026. PMID: 42527308. doi:10.3174/ajnr.A9550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。